Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electroconductive Soft Microcarriers for Suspension Culture of Skeletal Muscle Cells.

Macromolecular bioscience·2026
Same author

Transforming PRP into a shelf-stable therapy: Lyophilization preserves angiogenic and regenerative properties.

Iranian journal of basic medical sciences·2026
Same author

CAR-T Cell-Derived Exosomes and Cancer Immunotherapy: Advancing Production and Delivery Through Biofabrication.

Biofabrication·2026
Same author

Editorial: Fiber-based biomaterials for tissue engineering and regenerative medicine.

Frontiers in bioengineering and biotechnology·2026
Same author

Pericardial fluid extracellular vesicles enhance angiogenesis and blunt cardiac fibrosis in coronary disease.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.

Advanced drug delivery reviews·2026

Related Experiment Video

Updated: Mar 16, 2026

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
06:30

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

5.0K

Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies.

Mohammad Hossein Mohammadi1, Behnaz Heidary Araghi2, Vahid Beydaghi1

  • 1Department of Chemical and Petroleum Engineering, Sharif University of Technology, Azadi Ave, Tehran, Iran.

Advanced Healthcare Materials
|August 23, 2016
PubMed
Summary
This summary is machine-generated.

Tissue engineering and microfluidics advance in vitro skin models for chemical testing and disease research. Integrating these fields creates sophisticated skin-on-chip platforms for improved drug screening and novel disease modeling.

Keywords:
microfluidicsorgan-on-chipskin diseasetissue engineering

More Related Videos

Organotypic Tissue Model Systems for Investigating Host-Pathogen Interactions In Vitro
08:41

Organotypic Tissue Model Systems for Investigating Host-Pathogen Interactions In Vitro

Published on: March 28, 2025

1.3K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.7K

Related Experiment Videos

Last Updated: Mar 16, 2026

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform
06:30

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

5.0K
Organotypic Tissue Model Systems for Investigating Host-Pathogen Interactions In Vitro
08:41

Organotypic Tissue Model Systems for Investigating Host-Pathogen Interactions In Vitro

Published on: March 28, 2025

1.3K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.7K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Drug Discovery

Background:

  • Tissue engineering and microfluidics have advanced in vitro skin substitute development.
  • Organ-on-chip platforms integrate microfluidics and biomaterials for disease modeling.
  • Current skin disease models on organ-on-chip platforms are limited.

Purpose of the Study:

  • To review the impact of tissue engineering, biomaterials, and microfluidics on skin grafts and in vitro skin models.
  • To discuss the integration of these fields for biomimetic skin-on-chip platforms.
  • To explore applications in improving existing skin models and developing novel skin disease platforms for drug screening.

Main Methods:

  • Literature review of tissue engineering, microfluidics, and biomaterials in skin modeling.
  • Analysis of current organ-on-chip technologies for skin applications.
  • Discussion on the integration of microfluidic and tissue engineering principles.

Main Results:

  • Significant contributions of tissue engineering and microfluidics to in vitro skin substitutes.
  • Emergence of organ-on-chip platforms for physiologically relevant disease models.
  • Identification of limitations in current skin disease-on-chip models.

Conclusions:

  • Integration of tissue engineering and microfluidics is crucial for advanced biomimetic skin-on-chip platforms.
  • These integrated platforms offer potential for enhanced skin model performance.
  • Novel skin disease platforms for drug screening can be developed using this integrated approach.